What does CA — cash equivalents at carrying value mean?

This metric reports the total value of highly liquid, short-term investments held within the CA segment that are readily convertible to cash. It provides insight into the segment's immediate liquidity position and its ability to fund operational requirements or capitalize on short-term market opportunities. Maintaining an appropriate level of cash equivalents is critical for managing the segment's working capital and mitigating short-term financial risk.

BioSig Technologies, Inc. STEX CA — Cash Equivalents At Carrying Value

Other geography segments

$1.95M—

Similar metrics at other companies

WINACA — Cash

$191.5K+159%

BCSFCash And Cash Equivalents At Carrying Value

$12.97M+27.6%

BCSFCash Equivalents At Carrying Value

$13.59M—

MFICCash And Cash Equivalents At Carrying Value

$42.63M-49.1%

MFICCash Equivalents At Carrying Value

$255K-86.2%

INT

INTGCash Equivalent At Carrying Value

$8K—

Other financials

Income statement

See full

Revenue$13.0K+8.3%

Gross profit$12.0K-88.9%

Operating income-$35.7M-1,098%

Net income-$46.7M-1,560%

EPS (diluted)-$0.27-92.9%

Balance sheet

See full

Cash & equivalents$6.9M+84.0%

Total debt$15.0K-94.7%

Total equity$159.0M+6,003%

Total assets$173.3M+3,823%

Cash flow

See full

Operating cash flow-$10.2M-813%

CapEx$4.0K-93.1%

Free cash flow-$2.9M+29.4%

Valuation

See full

Market cap$88.66M-61.8%

P/S2,216.6×-5,967×

Profitability

See full

Gross margin80.1%+25.2pp

Operating margin-32,155%-14,261pp

Net margin-25,825%-11,789pp

FCF margin-97,216.7%-106,293pp

Returns & leverage

See full

Return on equity-627.1%—

Debt / equity0×—

Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashEquivalentsAtCarryingValue.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s ca — cash equivalents at carrying value.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioSig Technologies, Inc.'s CA — cash equivalents at carrying value?: BioSig Technologies, Inc. (STEX) reported CA — cash equivalents at carrying value of $4.91M in Q1 2026.
What does CA — cash equivalents at carrying value mean?: This metric reports the total value of highly liquid, short-term investments held within the CA segment that are readily convertible to cash. It provides insight into the segment's immediate liquidity position and its ability to fund operational requirements or capitalize on short-term market opportunities. Maintaining an appropriate level of cash equivalents is critical for managing the segment's working capital and mitigating short-term financial risk.